Trial site
Osaka University Hospital
- 23running trials
- 12closed trials
The trials here
What the 35 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer7 trials
- Childhood cancers4 trials
- Colorectal cancer2 trials
- Fabry disease2 trials
- Prostate cancer2 trials
- Thyroid cancer2 trials
- Triple-negative breast cancer2 trials
- Ulcerative colitis2 trials
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Crohn's disease1 trial
- Diabetic eye disease1 trial
- and 13 more
- Phase
- Phase 324 trials
- Phase 23 trials
- Phase 12 trials
- Phase 2/32 trials
- Status
- Active, not recruiting18 trials
- Completed11 trials
- Recruiting5 trials
- Terminated1 trial
- Lead sponsor
- Pfizer8 trials
- Hoffmann-La Roche3 trials
- Eli Lilly and Company2 trials
- Gilead Sciences2 trials
- Osaka University2 trials
- and 18 more
Running trials
Recruiting
A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer
Recruiting
Recruiting
Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
Active, not recruiting
A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease
Active, not recruiting
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Active, not recruiting
Active, not recruiting
Recruiting
Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Fabry disease1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Completed
Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC
Completed
Completed
Targeted Alpha Therapy Using Astatine (At-211) Against Differentiated Thyroid Cancer
Terminated
Completed
A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure
Completed
Completed
A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
Completed
Completed
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026